Ad Code: Tecentriq - Display Banners Conference - CPE - Limited Data - 98683

CTNNB1 alterations affect outcomes in patients with hepatocellular carcinoma (HCC).

Black patients with HCC are less likely than White patients to receive curative treatment.

While patients with hepatocellular carcinoma largely felt independent, their caregivers reported burdens related to appointment logistics and emotional support.

HCC survival time is predicted by albumin-bilirubin grade, microvascular invasion, and distant metastases.

The following is a summary of “Survival outcomes with adjuvant immunotherapy after hepatic...

The following is a summary of “Identification of a predictive phosphoproteomic signature of...

The following is a summary of “Identification of molecular subtypes for integrated multi-omics...

The following is a summary of “Atezolizumab + bevacizumab versus lenvatinib as first-line systemic...

Researchers at the 2024 ASCO Annual Meeting found racial and ethnic disparities in palliative care use among patients with advanced hepatocellular carcinoma.

The Industry Expert Theater offers hour-long, nonaccredited educational presentations by industry leaders. These sessions will cover the latest advancements in oncology practices, products, services, and technologies.

What ASCO ancillary event are you excited to attend?

Are you traveling to Chicago for ASCO? Here’s some places to visit.

ASCO Voices has become an anticipated staple of the conference. It is an opportunity for physicians to share their platform and experiences on a scale unlike any other.